Invita D3

Colecalciferol, the active ingredient in Invita D3, is a vitamin D presented as an oral dietary supplement for oral administration. It helps maintain normal calcium and phosphate concentrations in the blood and is employed to prevent or correct vitamin D deficiency in both children and adults.

GNH USA supplies Invita D3 as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinical centres across global markets. The company adheres to stringent quality standards and offers reliable logistics for timely delivery.

Invita D3 (colecalciferol) is used to address disorders of vitamin D metabolism and related calcium homeostasis. - Vitamin D deficiency: restores adequate serum 25‑hydroxyvitamin D levels to support bone health. - Osteomalacia: promotes mineralization of the bone matrix in adults with softening of bones. - Rickets: aids in proper bone development and growth in children with deficient vitamin D. - Hypocalcemia due to vitamin D deficiency: increases calcium absorption to normalize serum calcium.

Common Side Effects: - Hypercalcemia: elevated blood calcium levels causing fatigue or nausea. - Nausea: mild gastrointestinal discomfort after ingestion. - Headache: transient mild head pain. - Dry mouth: reduced salivary flow. - Constipation: occasional difficulty passing stools.

Serious or Rare Side Effects: - Hypercalciuria: excessive urinary calcium excretion leading to kidney stones. - Severe hypercalcemia: may cause cardiac arrhythmias or neurological symptoms. - Allergic reaction: rash, itching, or swelling indicating hypersensitivity.

Before initiating therapy, consider the following precautions: - Assess baseline serum calcium: check levels to avoid hypercalcemia. - Monitor vitamin D status: periodic measurement of 25‑OH vitamin D recommended. - Avoid excessive calcium intake: counsel patients on dietary sources. - Use caution in renal impairment: adjust monitoring frequency. - Pregnancy and lactation: consult healthcare provider before use. - Store at ambient temperature: keep in original container, protect from moisture and light.

Potential drug interactions include: Major Interactions (Avoid): - Thiazide diuretics: may increase risk of hypercalcemia. - High-dose vitamin A: synergistic effect leading to hypercalcemia. - Aluminum-containing antacids: can reduce vitamin D absorption. Moderate Interactions (Monitor Closely): - Corticosteroids: may diminish vitamin D effectiveness. - Orlistat: may decrease absorption of fat‑soluble vitamins. - Anticonvulsants (phenytoin, phenobarbital): may increase vitamin D metabolism.